Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Smallpox is only alive in two labs. Should we destroy it?

A transmission electron micrograph of smallpox virus particles (virions)
A transmission electron micrograph of smallpox virus particles (virions)
A transmission electron micrograph of smallpox virus particles (virions)
UIG via Getty Images

Should we destroy the last living samples of smallpox? The World Health Organization will decide this month. Some major microbiologists are arguing that we should keep them to help develop smallpox treatments and that we should discuss possible new experiments with live smallpox to better understand it, in general.

The reasons to destroy the virus seem fairly obvious. After all, smallpox killed 300 million people in the 20th century. And despite all the best precautions, there’s a slight risk that it could escape. (Or that a worker could steal some.)

Smallpox is still the only human disease that’s ever been eradicated through an intentional campaign. Ever since the WHO declared the disease officially eradicated in 1980, people have been arguing about whether to destroy all of the samples for good. There are only two official locations with live smallpox samples: one in the US and one in Russia.

(I'm sparing you the photo of what smallpox looks like. If you really want to see it, click here. Just don't tell me that I didn't warn you.)

For the time being, the WHO is letting researchers keep smallpox in order to produce antiviral drugs, diagnostic tests, and safer vaccines that could be used in the event of a future outbreak. Expert opinions vary on whether these efforts are far enough along to justify destroying all of the virus.

The authors of the recent essay argue that the research is not yet finished. (For example, drugs are only in phase two of three-phase clinical trials.)

They also mention something that I hadn’t before considered: drug-resistant smallpox. “While the likelihood of the emergence of, or creation of, either drug- or vaccine-resistant versions of smallpox is unknown,” they say, “continued investigation to identify additional countermeasures, for example, through screening using functional genomics or proteomics approaches, can further enhance our state of preparedness.”

Basically, if you don’t know how likely smallpox is to become resistant to your vaccine, then you don’t really know how many versions of a vaccine you need.

And where could a new smallpox threat come from?

  • Bioterrorism from some unofficial test tube of smallpox that someone might have hidden away decades ago
  • Bioterrorism using currently available DNA sequence information to create a deadly smallpox-like virus
  • Smallpox from the grave. (No one knows how long smallpox can survive in a dead body, according to this Smithsonian article.)
  • New diseases. They’re always popping up, often after making the leap from some other animal to us, like a new smallpox cousin that appeared last week. Although that particular one doesn’t seem especially problematic so far, you never know when one might. Some of the reasons to study smallpox are actually to understand deadly diseases in general. Smallpox itself is particularly interesting because, unlike other viruses in its family, it only infects humans (and not any other animals). This unique quality is something worth studying, according to the authors of the essay.
See More:

More in archives

archives
Ethics and Guidelines at Vox.comEthics and Guidelines at Vox.com
archives
By Vox Staff
Supreme Court
The Supreme Court will decide if the government can ban transgender health careThe Supreme Court will decide if the government can ban transgender health care
Supreme Court

Given the Court’s Republican supermajority, this case is unlikely to end well for trans people.

By Ian Millhiser
archives
On the MoneyOn the Money
archives

Learn about saving, spending, investing, and more in a monthly personal finance advice column written by Nicole Dieker.

By Vox Staff
archives
Total solar eclipse passes over USTotal solar eclipse passes over US
archives
By Vox Staff
archives
The 2024 Iowa caucusesThe 2024 Iowa caucuses
archives

The latest news, analysis, and explainers coming out of the GOP Iowa caucuses.

By Vox Staff
archives
The Big SqueezeThe Big Squeeze
archives

The economy’s stacked against us.

By Vox Staff